rs2282983
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001145306.2(CDK6):c.647+21377A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.433 in 152,048 control chromosomes in the GnomAD database, including 14,933 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as association (no stars).
Frequency
Genomes: 𝑓 0.43 ( 14933 hom., cov: 32)
Consequence
CDK6
NM_001145306.2 intron
NM_001145306.2 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.03
Publications
10 publications found
Genes affected
CDK6 (HGNC:1777): (cyclin dependent kinase 6) The protein encoded by this gene is a member of the CMGC family of serine/threonine protein kinases. This kinase is a catalytic subunit of the protein kinase complex that is important for cell cycle G1 phase progression and G1/S transition. The activity of this kinase first appears in mid-G1 phase, which is controlled by the regulatory subunits including D-type cyclins and members of INK4 family of CDK inhibitors. This kinase, as well as CDK4, has been shown to phosphorylate, and thus regulate the activity of, tumor suppressor protein Rb. Altered expression of this gene has been observed in multiple human cancers. A mutation in this gene resulting in reduced cell proliferation, and impaired cell motility and polarity, and has been identified in patients with primary microcephaly. [provided by RefSeq, Aug 2017]
CDK6 Gene-Disease associations (from GenCC):
- autosomal recessive primary microcephalyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- microcephaly 12, primary, autosomal recessiveInheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.572 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CDK6 | NM_001145306.2 | c.647+21377A>G | intron_variant | Intron 5 of 7 | ENST00000424848.3 | NP_001138778.1 | ||
| LOC112268009 | XR_002956577.2 | n.12622A>G | non_coding_transcript_exon_variant | Exon 1 of 2 | ||||
| CDK6 | NM_001259.8 | c.647+21377A>G | intron_variant | Intron 5 of 7 | NP_001250.1 | |||
| CDK6 | XM_047419716.1 | c.647+21377A>G | intron_variant | Intron 5 of 7 | XP_047275672.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CDK6 | ENST00000424848.3 | c.647+21377A>G | intron_variant | Intron 5 of 7 | 1 | NM_001145306.2 | ENSP00000397087.3 | |||
| CDK6 | ENST00000265734.8 | c.647+21377A>G | intron_variant | Intron 5 of 7 | 1 | ENSP00000265734.4 | ||||
| ENSG00000286742 | ENST00000668236.1 | n.113+2031T>C | intron_variant | Intron 1 of 2 |
Frequencies
GnomAD3 genomes AF: 0.433 AC: 65731AN: 151932Hom.: 14909 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
65731
AN:
151932
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.433 AC: 65815AN: 152048Hom.: 14933 Cov.: 32 AF XY: 0.436 AC XY: 32360AN XY: 74300 show subpopulations
GnomAD4 genome
AF:
AC:
65815
AN:
152048
Hom.:
Cov.:
32
AF XY:
AC XY:
32360
AN XY:
74300
show subpopulations
African (AFR)
AF:
AC:
23970
AN:
41470
American (AMR)
AF:
AC:
6664
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
AC:
1612
AN:
3470
East Asian (EAS)
AF:
AC:
1415
AN:
5172
South Asian (SAS)
AF:
AC:
1857
AN:
4824
European-Finnish (FIN)
AF:
AC:
4027
AN:
10560
Middle Eastern (MID)
AF:
AC:
147
AN:
294
European-Non Finnish (NFE)
AF:
AC:
24862
AN:
67958
Other (OTH)
AF:
AC:
922
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1869
3739
5608
7478
9347
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
590
1180
1770
2360
2950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1405
AN:
3476
ClinVar
Significance: association
Submissions summary: Other:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Behcet disease Other:1
Nov 14, 2021
Chongqing Key Laboratory of Ophthalmology and Chongqing Eye Institute, The First Affiliated Hospital of Chongqing Medical University
Significance:association
Review Status:no assertion criteria provided
Collection Method:case-control
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.